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Abstract
Background: Safe and timely access to effective and appropriate medication through primary care settings is a
major concern for all countries addressing both acute and chronic disease burdens. Legislation for nurses and
other professionals allied to medicine to prescribe exists in a minority of countries, with more considering
introducing legislation. Although there is variation in the range of medicines permitted to be prescribed, questions
remain as to the contribution prescribing by nurses and professionals allied to medicine makes to the care of
patients in primary care and what is the evidence on which clinicians, commissioners of services and policy makers
can consider this innovation.
Methods: A integrative review of literature on non-medical prescribing in primary care was undertaken guided by
dimensions of health care quality: effectiveness, acceptability, efficiency and access.
Results: 19 papers of 17 empirical studies were identified which provided evidence of patient outcome of non
medical prescribing in primary care settings. The majority were undertaken in the UK with only one each from the
USA, Canada, Botswana and Zimbabwe. Only two studies investigated clinical outcomes of non-medical
prescribing. Seven papers reported on qualitative designs and four of these had fewer than ten participants. Most
studies reported that non medical prescribing was widely accepted and viewed positively by patients and
professionals.
Conclusions: Primary health care is the setting where timely access to safe and appropriate medicines is most
critical for the well-being of any population. The gradual growth over time of legislative authority and in the
numbers of non-medical prescribers, particularly nurses, in some countries suggests that the acceptability of non-
medical prescribing is based on the perceived value to the health care system as a whole. Our review suggests
that there are substantial gaps in the knowledge base to help evidence based policy making in this arena. We
suggest that future studies of non-medical prescribing in primary care focus on the broad range of patient and
health service outcomes and include economic dimensions.
Background
Safe and timely access to effective and appropriate med-
ication through primary care settings is a major concern
for all countries addressing both acute and chronic dis-
ease burdens [1]. From the nineteenth century onwards,
governments have responded to concerns for public
protection and concerns about drug misuse through
medicine regulation legislation. By the twentieth
century, legislation started to incorporate prescriptive
authority restricted to a small number of occupational
groups such as doctors, dentists and vets for certain
classes of drugs [2]. Medicine regulation has developed
at different rates in high and low income countries, as
has the mechanisms to enforce them. The development
in the later part of the twentieth century of a more
effective range of medicines has seen a different set of
public health preoccupations which range from the pre-
vention of antibiotic resistance, to issues both of how to
fund and contain medicine costs in health care systems
and at the same time ensure equity of access for citizens
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country places different emphasis on these issues but in
many it has led to consideration of the use of other
health professional groups in addition to doctors to pre-
scribe regulated classes of medicines or medicines pro-
vided through a state sponsored or funded health care
provision.
Non-medical prescribing (NMP) is one term that is
used to describe the extension of prescriptive authority
to professional groups other than the medical profession
such as nurses, midwives and allied health professions.
Data is not easily available on the extent of NMP for all
194 member states of the World Health Organisation.
We have identified, through internet searches, the litera-
ture search described below and personal communica-
tions, 22 countries which have legislation giving
prescriptive authority to nurses (see Table 1[3,4]).
Some other countries, for example Spain, the Nether-
lands, Finland, Jamaica and Hong Kong have initiated
efforts to introduce legalisation on NMP [4]. There is
great variety in the prescribing legislation of different
countries. Some countries legislate for the initial qualifi-
cation and registration of the nurse as sufficient to
undertake prescribing certain classes of medicines and
in certain situations, for example Kenya, while others
require further qualifications, for example Namibia.
Within a country there can also be variations between
the extent of classes of medicines nurses can prescribe
either as a result of different state legislation, for exam-
ple the United States of America (USA) or different
levels of prescribing qualifications, for example in the
United Kingdom (UK). In the UK ‘independent prescrib-
ing’ qualifications allows almost all medicines to be pre-
scribed within the individual’s clinical competence and
‘community practitioner prescribing’ qualification gives
only authority over a small limited nurses formulary. In
addition, many countries have mechanisms whereby
individual nurses (or other professionals) have authority,
agreed by their employer and/or doctor responsible for
a service, to prescribe and dispense or administer a spe-
cified list of medicines to a pre-defined group of
patients in specific circumstances and within specified
parameters. Common international examples of this are
within public health immunisation programmes [5].
These are known by a variety of names such as standing
orders. In the UK these are known as patient group
directions [6] and are used widely across the spectrum
of health services [7].
In the last fifty years different models of primary care
have developed in countries, influenced by health care
funding, government policies and the aspirations of
family medicine and general practice [8]. The extent to
which groups of professionals such as nurses and phar-
macists are present in the primary care system of each
Table 1 Countries with identified legislation for Prescribing by Nurses
Country Legal Framework for Non-medical prescribing (NMP)
Australia The Drugs Poisons and Controlled Substances Act 1981 and Nurses Act 1993 (Vic) amended with Nurse Amendment Act
2000*.
Botswana The Drugs and Related Substances Act 1992 grants legal authority to RGN to prescribe specific drugs from Botswana
National Drug Formulary***.
Canada The College of Registered Nurses of Nova Scotia Regulations (Section 27, 2002), approved by government, enabled NPs
to prescribe from a restricted list of medications known as the Authorized Practices Schedule*.
Kenya Public Health Act Cap 242 of the laws of Kenya allows nurses to diagnose and treat minor illnesses in settings without
doctors *.
New Zealand A 2001 regulation under the Medicines Act 1981 enables nurse practitioners to become designated prescribers within
their defined area of practice (e.g., primary health)*.
Namibia Under Nursing Act (8) 2004 in Namibia Nurse Prescribers are allowed to prescribe up to Schedule 4 medicines once they
have concluded a primary care training course from the Department of Health***.
Republic of Ireland Introduced in 2007. The Irish Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006) and its associated
regulations and the Nurses Rules 2007 [3].
South Africa The Section 38A of the Nursing Act, 1978 give rights to nurses to prescribe certain classes of medicine. The 38A section
of Nursing Act no longer exists and Act 101 of the Medicines and Related Control Act 1965 amended in 1997 allows to
nurses to become an authorised prescriber*.
Sweden Introduced in 1994. District Nurses may prescribe from a National Board of Health and Welfare *.
Uganda National Drug Policy and Authority Statute 1993 was amended in 2004, which allows nurses to prescribe***.
United Kingdom (UK) The Medicinal Products: Prescription by Nurses etc Act 1992, The Health and Social Care Act 2001**.
United States of America
(USA)
Nurse Prescribing (NP) introduced in 1969. Fifty States allow some form of NMP. However, there is no uniformity in law,
language and regulations among States*.
In addition we are aware that NPM legislation exists in Cameroon, Zimbabwe, Rwanda, Swaziland, Malawi, Tanzania, Zambia, Ghana, Lesotho and
Ethiopia****, but were unable to identify the specific legislative documents.
*International Council of Nursing 2009 [4] ** Department of Health *** Personal communication **** Internet search
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policy imperatives. This varies between countries even
neighbouring in the same continent, for example, the
UK has seen significant numbers of nurses employed in
general practice over the past thirty years [9], where as
there are small numbers of nurses employed in primary
care in France [10].
Extending prescribing authority in primary care is a
health care innovation driven by various factors in each
country. Addressing shortages of medical staff particu-
larly in remote and rural areas has been one driving fac-
tor in North America, Africa and Australia [11,12]. In
African countries such as South Africa, Botswana,
Uganda and Zimbabwe, the aim has been to meet com-
munity health care needs by improving access to medi-
cines [13]. In Sweden, the UK and New Zealand; NMP
was commenced in order to improve the efficiency of
services for specific groups, such as elderly people or
those who receive nursing care in the community
[14,15]. In some countries, the aspirations of profes-
sional groups have been significant in changes to the
legislation [16] but only when they have coincided with
other public health and health policy imperatives. In
summary, the key policy goals to date have been to
improve patient access in primary care settings to safe,
timely and effective medicines and increasing the effi-
ciency of health service delivery. However, NMP exists
in a minority of countries and the extent of prescriptive
authority is contentious in some [17]. A sociological
narrative review has explored these dimensions further
[18]. Other recent narrative reviews [19,20] have consid-
ered nurse prescribing in any setting without acknowl-
edging that prescribing in primary care is a very
different context from a hospital setting. In primary care
settings the prescriber may have little immediate access
to other professionals and may be seeing patients with
previously undiagnosed illnesses. Therefore the question
remains as to the contribution NMP makes to the care
of patients in primary care and what is the evidence on
which clinicians, commissioners of services and policy
makers can consider this innovation.
There is increasing interest in many health care sys-
tems to evaluate interventions and innovations in terms
of the outcomes for patients, rather than just examine
structural and process elements. Donabedian defines the
outcome of care as “the effects of care on the health sta-
tus of patients and populations. Improvements in the
patient’s knowledge and salutary changes in the patient’s
behaviour are included under a broad definition of
health status, and so is the degree of the patient’ss a t i s -
faction with care” [21], p. 1745. Donabedian differenti-
ates this from the structural elements i.e. the attributes
of the setting in which care occurs and the process ele-
ments i.e. what is actually done in giving and receiving
care [21]. This paper reports on an integrative review of
the empirical literature [22] which addressed the ques-
tion what is the effect of NMP in primary care and
community settings on patient outcomes?
Methods
A search strategy was devised to include published and
grey literature. The electronic data bases CINAHL,
MEDLINE, BNI, AMED, ISI Web of Knowledge and
Index to theses were searched. A search to retrieve grey
literature was also conducted of relevant websites: Goo-
gle scholar, the Royal College of Nursing, Royal Pharma-
ceutical Society, NHS Modernisation Agency, King’s
Fund, National Institute of Clinical Excellence, Depart-
ment of Health, and National Prescribing Centre.
Searches also included follow up of reference lists and
key authors. Searching was conducted by SB according
to the inclusion and exclusion criteria, using terms of
NMP.
The search terms employed were nurse prescribing,
non-medical prescribing, supplementary prescribing,
independent prescribing, pharmacist prescribing, allied
health professional prescribing, prescribing rights and
prescribing impact and outcomes. A combination of
these search terms was used. All items within each
terms section were combined with OR and then each
section was combined with AND for different combina-
t i o n so fs e c t i o n st h a tp r o d u c e dt h eh i g h e s tr e s u l t .T h e
inclusion criteria and the exclusion criteria were as
follows:
Inclusion criteria
￿ Study contains empirical evidence of NMP from
any professional group with legislative authority
￿ Study contains empirical evidence of outcomes
￿ Setting: primary care and community
￿ Search period: January 1970 - December 2010 for
the USA and October 1994 - December 2010 for the
UK and other countries. These timeframes reflect
the years when non-medical prescribing was intro-
duced in these countries.
Exclusion criteria
￿ Studies that did not meet inclusion criteria above
￿ Commentaries, editorials, opinions, guidelines and
service audits
￿ Papers that did not report the research design or
methods used
Abstracts were identified, screened by two researchers
and accepted or rejected based on the inclusion and
exclusion criteria. Full papers were obtained where the
abstract was unclear to enable an accurate decision. Full
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on sample size, prescribing authority type, findings on
outcomes and process outcomes (as defined above) and
study limitations were extracted. Each study was consid-
ered against the adapted quality checklists relevant to
the study design [23,24]. Regular meetings were held
between the researchers to discuss and agree interpreta-
tions and to clarify any inconsistencies in the evidence.
Due to the heterogeneity of study methods, partici-
pants and outcomes, an overall meta-analysis was not
appropriate. Instead data are presented narratively
through a synthesis framed by the dimensions of judging
health care suggested by Maxwell [25]. These dimen-
sions are of the effectiveness, acceptability, efficiency,
equity (fairness) and access to health care. The defini-
tions as described by Maxwell were used. Effectiveness
addresses questions of “whether the treatment or inter-
vention is the best available in the technical sense and
the overall result of the treatment” [25], p. 171. Accept-
ability considers questions of patient’s perceptions. Effi-
ciency considers questions of “whether the output is
maximised for the given input or conversely whether
the input is minimised to achieve the stated output”
[ 2 5 ] ,p .1 7 1 .F i n a l l y ,a c c e s sc o n s i d e r st h eq u e s t i o n so f
whether people receive treatment/service when they
need it [25].
Results
The initial searches produced 1734 abstracts, of which
961 duplicate articles were removed. Titles and abstracts
were screened by SB and VMD. After reading titles and
abstracts 375 of the 773 papers were excluded. The
remaining 398 papers were classified into three cate-
gories: empirical papers (n = 184), opinion papers (n =
209) and literature reviews (n = 5). The opinion papers
and reviews were excluded.
One hundred and three of the 184 empirical papers
were excluded as they did not relate to primary care set-
tings and 17 were excluded as they reported combined
p r i m a r ya n da c u t ec a r ed a t aa n di tw a sn o tp o s s i b l et o
separate the data relating to primary care (see table 2
[26-41]). The full text of the remaining 64 papers were
read (SB, RG, RH and VMD) and categorised as to
whether they addressed questions of structure, process,
or outcomes of NMP in primary care. Those presenting
evidence only on the structure or process were excluded
(n = 41). In six of the twenty-three remaining papers
the research question and/or method were unclear or
omitted important information to enable the quality of
the paper to be assessed and were therefore excluded. A
t o t a lo f1 9a r t i c l e so f1 7s t u d i e sr e p o r t i n go nt h eo u t -
comes of NMP were included in the review (Figure 1).
Two studies used the same data for two publications.
Details of the papers are given in Additional File 1.
Most studies were conducted in the UK. The majority
investigated the contribution of nurses as a non-medical
prescriber with a small number investigating the more
recent development of pharmacists as non-medical pre-
scriber (Table 3). Of the 17 studies, seven used qualita-
tive methods only, eight quantitative methods and two
employed mixed methods designs. We now turn to con-
sider the evidence within the studies as grouped by
questions of effectiveness, efficiency, acceptability and
access. Issues of equity are considered within the section
on access.
Effectiveness
Effectiveness addresses questions of whether the treat-
ment or intervention is the best available in the techni-
cal sense and the overall result of the treatment [25].
Fifteen of the seventeen studies investigated some aspect
of the effectiveness of NMP in primary care. Of these 15
studies, thirteen investigated nurse prescribing and two
pharmacists prescribing. Six of these studies used quali-
tative semi-structured and in-depth interviews [42-47],
seven used quantitative questionnaire surveys and sec-
ondary data analysis [48-54] and two applied a mixed
methods approach [55,56]. The majority of studies con-
sidered effectiveness of service delivery and only one of
the studies considered therapeutic effectiveness [53].
Four studies from UK, Canada, Botswana and Zim-
babwe, which analysed patient clinical accounts,
reported substantial increases in the prescription by
NMP of non-steroidal anti-inflammatory [49], cardiovas-
cular [50] and antibiotic medicines [54-56]. They give
an indication of both the conditions that non-medical
prescribers were encountering and also of the numbers
or confidence of non-medical prescribers to prescribe
these medicines. Only two studies presented compara-
tive data from general practitioners indicating similar
frequency of prescribing but not by groups of medicines
[51,53].
Three studies describing patient views [[43,48] and
[57]] and one of clinical consultation review [58]
reported that NMP were effective in improving the pro-
vision of information, advice and understanding on
treatment, conditions, self-care and standard of care.
One study describing data from the professional view-
points reported that NMP had enhanced concordance
with patients [46]. One study which analysed clinical
r e c o r d s[ 5 3 ]r e p o r t e dt h a tt h eN M Pi n t e r v e n t i o n
improved patient reported outcomes of treatment. None
of these studies present any other data as evidence to
support these viewpoints.
Most of the studies were not able to comment on the
effectiveness of NMP in primary care in relation to
safety and appropriateness of prescribing by nurses and
other professionals allied to medicine. However, there is
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countries that some prescribing of antibiotics by those
nurses may have been inappropriate and not evidence-
based [54,56]. Neither presents comparative data to
judge whether other professionals such as doctors in
that type of setting prescribed in similar or different
ways. A mixed methods survey of adherence to treat-
ment guidelines in primary health care facilities in Bots-
wana found that antibiotics were prescribed in 27% of
all 2994 consultations. The study reported that full
adherence to prescribing guidelines (defined as complete
adherence to national recommended treatment guide-
lines) occurred in 44% of prescriptions, acceptable com-
pliance in 20%, acceptable but with one or more useless
although not dangerous drugs in 33% and insufficient or
dangerous treatment in 3% of the consultations [56]. An
unspecified survey of antibiotic prescribing by nurses in
primary care clinics in Harare, Zimbabwe found that of
1000 patient (presumably records but not specified in
the paper) surveyed 543 were prescribed with antibio-
tics. It was reported that 12.3% of patients were pre-
scribed antibiotics inappropriately [54]. The same study
referenced an unpublished paper reporting on a pre-
vious small survey which was carried out in a paediatric
p r i m a r yc a r ec l i n i ci nZ i m b a b w e .T h es t u d yr e p o r t e d
that 55% of children were treated with antibiotics when
seen by the nurses but only 22% when seen by a paedia-
trician [59].
Efficiency
Efficiency considers questions of whether the output is
maximised for the given input or conversely whether
Table 2 Papers and reports with combined primary care and secondary care data
Complete reference Country
Latter S, Blenkinsopp, A., Smith, A., Chapman, S., Tinelli, M., Gerard, K., Little, P., Celino, N., Granby, T., Nicholls, P., Dorer, G.:
Evaluation of nurse and pharmacist independent prescribing. London: University of Southampton & Keele University; 2010
[26].
UK
Hoti K, Sunderland B, Hughes J, Parsons R: An evaluation of Australian pharmacist’s attitudes on expanding their
prescribing role. Pharmacy World & Science: PWS 2010, 32(5):610-621 [27].
Australia
Hacking S, and Taylor, J: An evaluation of the scope and practice of non-medical prescribing in the North West for NHS
North West. Lancashire: School of Nursing & Caring Sciences, University of Central Lancashire 2010 [28].
UK
Hobson RJ, Scott J, Sutton J: Pharmacists and nurses as independent prescribers: exploring the patient’s perspective. Family
Practice 2009, 27(1):110-120 [29].
UK
Drennan J. NC, Allen D., Hyde A., Felle P., O’Boyle K., Treacy P., Butler M.: Independent Evaluation of the Nurse and Midwife
Prescribing Initiative. Dublin: University College Dublin; 2009 [3].
Republic of
Ireland
Courtenay M, Stenner K, Carey N: An exploration of the practices of nurse prescribers who care for people with diabetes: a
case study. J Nursing & Healthcare of Chronic Illness 2009, 1(4):311-320 [30].
UK
Dunn SV, Cashin A, Buckley T, Newman C: Nurse practitioner prescribing practice in Australia. Journal of the American
Academy of Nurse Practitioners 2008, 22(3):150-155 [31].
Australia
Courtenay M, Carey N: Nurse independent prescribing and nurse supplementary prescribing practice: national survey.
Journal of Advanced Nursing 2008, 61(3):291-299 [32].
UK
Courtenay M, Carey N: Preparing nurses to prescribe medicines for patients with diabetes: a national questionnaire survey.
Journal of Advanced Nursing 2008, 61(4):403-412 [33].
UK
Cooper R, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, Lymn J, Murphy E, Ratcliffe J, Ward P: Stakeholders’ views of
UK nurse and pharmacist supplementary prescribing. Journal of Health Services Research & Policy 2008, 13(4):215-221 [34].
UK
Bissell P, Cooper, R., Guillaume, L., Anderson, C., Avery, A., Hutchinson, A., James, V., Lymn, J., Marsden, E., Murphy, E., Ratcliffe, J.,
Ward, P., and Woolsey, I: An Evaluation of Supplementary Prescribing in Nursing and Pharmacy. London: Department of
Health 2008 [35].
UK
Latter S, Maben J, Myall M, Young A, Baileff A: Focus. Evaluating prescribing competencies and standards used in nurse
independent prescribers’ prescribing consultations: an observation study of practice in England. Journal of Research in
Nursing 2007, 12(1):7-28 [36].
UK
Latter S, Maben J, Myall M, Young A: Evaluating the clinical appropriateness of nurses’ prescribing practice: method
development and findings from an expert panel analysis. Quality & Safety in Health Care 2007, 16(6):415-421 [37].
UK
Courtenay M, Carey N, Burke J: Independent extended and supplementary nurse prescribing practice in the UK: a national
questionnaire survey. International Journal Of Nursing Studies 2007, 44(7):1093-1101 [38].
UK
George J, McCaig DJ, Bond CM, Cunningham ITS, Diack HL, Watson AM, Stewart DC: Supplementary prescribing: early
experiences of pharmacists in Great Britain. The Annals Of Pharmacotherapy 2006, 40(10):1843-1850 [39].
UK
Flenniken MC: Psychotropic prescriptive patterns among nurse practitioners in nonpsychiatric settings. Journal of the
American Academy of Nurse Practitioners 1997, 9(3):117-121 [40].
USA
Batey MV, Holland JM: Prescribing practices among nurse practitioners in adult and family health. American Journal of Public
Health 1985, 75(3):258-262 [41].
USA
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Of the 17 studies nine considered questions of effi-
ciency; seven of them as a part of a broader study and
two considered only questions of efficiency using
qualitative [42,45] and quantitative [58] methods. All
these studies reported prescribing by nurses.
Four studies, one of patient [42] and three of profes-
sional views [[44,47] and [55]], reported that NMP was

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total search: 1734 
Empirical studies: 184 
Removed opinion papers: 209 
Primary Care: 64 
Structure: 10 
Removed not Primary Care: 103  
Removed after quality check: 06 
Included in this review: 17 
Removed Duplicates: 961 
Remaining: 773 
Removed after reading titles & abstracts: 
375 
Remaining: 398  
Outcome: 23  Process: 31 
Literature Reviews: 05 
Removed papers with combined data: 17 
Figure 1 Flow chart of the selection of papers in review.
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timely without the need to wait for a GP appointment.
Two studies of nurses’ views reported that being able to
prescribe enabled them to provide seamless and patient
centred care [45,46]. A UK based observational survey
of clinical accounts reported that nurse prescribers fully
completed the episode of care, i.e. did not have to refer
on to a doctor, in 65% of patients presenting in the
same day appointments using a combination of advice
and prescriptions [58]. In an American evaluation of
Advanced Nursing Practitioners (ANP) with prescriptive
authority 1,708 patients were seen and prescribed by 32
ANPs. An analysis of patient records found that patients
experienced short waiting times (63% waited 15 minutes
or less) [53]. A Canadian study which analysed two
years of prescription claims by older adults reported
that the number of prescriptions per nurse prescriber
doubled and cost per prescription increased approxi-
mately 20% over the time period [49]. The authors
noted the increase in cost per prescription; however,
they did not interpret this in terms of efficiency. While
three studies describing the professional views [[44,49]
and [55]] reported that NMP was time saving for patient
and nurses only one study, which was conducted in the
UK, reported NMP as a cost-effective intervention [47].
Acceptability
Acceptability considers questions of suitability and satis-
faction from the perspective of both those receiving the
intervention (the patients) and others providing or com-
missioning the service (the professionals and managers)
[25]. It therefore relates to perceptions of outcomes. Of
the 17 studies in the review, three reported views about
acceptability as a part of a broader study. Of these three
studies, two investigated nurse prescribing and one
pharmacist prescribing. The studies found that NMP
was widely accepted and viewed positively by patients
[[42,43,48] and [60]]. A UK based qualitative study that
interviewed 50 patients from caseloads of health visitors
(n = 17), district nurses (n = 9) and a practice nurse (n
= 1) reported that 49 (98%) out of 50 study participants
were in favour of nurse prescribing and happy with the
consultation and information provided by the nurse pre-
scribers [42]. Similarly, another UK based study inter-
viewed a sample of 148 patients selected from the
caseloads of district nurses, health visitors and practice
nurses after the treatment episode involving non-medi-
cal prescriber. The majority of patients interviewed post
prescribing implementation, were in favour of nurse
prescribing and 55% of patients interviewed had sought
advice from a nurse prescriber in preference to the GP
[43].
Access
Access considers the questions of whether people
receive a treatment or service when they need it and
whether there are any identifiable barriers to service
uptake [25]. Five studies considered the question of
access as a part of a broader study. Four studies consid-
ered nurse prescribing and one pharmacist prescribing
from UK. Four patient views studies [[42,43,48] and
[61]] and one clinical consultation review analysis [58]
reported that introduction of NMP has improved access
to medicines and health care professionals. A UK based
qualitative study, which interviewed 41 patients from
caseloads of seven nurse prescribers, reported that they
thought that their access to medicine had improved dur-
ing non-routine/non-emergency appointments [61].
Similarly, another UK study interviewed 305 patients
selected from the caseloads of nurse prescribers
reported that patients appreciated the nurses being
accessible resulting in no delay in starting medication
[43]. A questionnaire study investigating the patients’
experience (n = 127) of pharmacist-led supplementary
prescribers in a UK primary care setting reported that
86% of respondents stated that they are able to make
appointments easily, which resulted in improved access
to medicines [48].
Discussion
While there have been previous published reviews of
non-medical prescribing, none have considered the evi-
dence from one setting, in this case primary care, or
have focused on outcomes.
In this review, 19 papers of 17 empirical studies (two
studies published two articles each) were identified
which provided evidence of patient outcome of NMP in
p r i m a r yc a r es e t t i n g s .T h em a j o r i t yw e r eu n d e r t a k e ni n
the UK with only one each from the USA, Canada,
Botswana and Zimbabwe. Seven papers report on UK
studies of nurse prescribing from a limited nurses’ for-
mulary. Seven papers reported on qualitative designs
and four of these had fewer than ten participants. Two
reported on surveys of opinion and experience. Eight
papers reported on record reviews of prescriptions or
clinical consultation by NMPs. Those studies that
Table 3 Distribution of papers by country and type of
NMP
Country No. Of papers Nurses Pharmacists
UK 11 X
02 X
USA 01 X
Canada 01 X
Botswana 01 X
Zimbabwe 01 X
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one provided some comparative evidence of another
type of prescriber, GPs, by which to judge the impact
on patient outcomes or outcomes on the efficiency for
the health system [52]. While there may be a publication
bias in reporting positive outcomes present in those
identified, many of the studies included in the review
had design weaknesses and limitations, both as indicated
by the authors and evident through critical appraisal of
the papers. The strength of evidence they provide on
the whole is limited.
The review findings from stakeholders’ perspectives
s u g g e s tt h a tN M Pi np r i m a r yc are effectively improves
patients’ understanding of treatment, condition and self-
care and provides a better level of care. As the literature
suggests that concordance is a major issue in the effec-
tive use of medicines in primary care settings [62] the
impact of additional information and advice may be sig-
nificant in considering which type of prescriber is effec-
tive for which particular patient groups. This
proposition requires further testing and investigation.
We found very limited evidence in relation to other
indicators of effectiveness of NMP outcomes such as of
patient safety and clinical outcomes. The overall number
of research-based studies to evaluate impact and out-
come of NMP was low given that NMP was introduced
in many countries over 30 years ago. In part this
reflected the number of papers excluded as it was not
possible to separate primary care related data from sec-
ondary care related data but it may also be that NMP is
seen as producing positive outcomes in situations where
there are no alternative prescribers. This may explain
the absence of empirical outcome evidence from low
income countries in particular, although this may also
reflect the review search strategy, which did not search
country specific journals not indexed on the major elec-
tronic databases. Given that it is a minority of countries
that have given prescribing authority to professionals
other than doctors and dentists, it may be that it is this
type of evidence that would be of value to policy makers
and requires further investigation and publication.
In relation to efficiency of NMP in primary care, the
review suggests that patients received services that were
timely, seamless and of high quality from nurse and
pharmacist prescribers. One study reported opinions
that NMP was cost effective in primary care. We were
unable to find any papers from a health economics per-
spective or that modelled the efficiency impact from
either patient or the health services perspective. We sug-
gest that this is an aspect that warrants further
investigation.
All the studies investigating acceptability of NMP indi-
cated that NMP was well accepted and favoured by
patients, nurses, pharmacists and other health care
professionals. The gradual growth over time of legisla-
tive authority to NMP and also of the numbers of non-
medical prescribers, particularly nurses, in countries
such as the USA and the UK, suggests that the accept-
ability is based not just on immediate levels of satisfac-
tion with the clinical encounter but perceived value to
the health care system as a whole.
The review findings also report that patients consid-
ered it was easier, quicker and convenient to get an
appointment with NMP and their access to medicine
and health care professionals was improved. For all
countries the issue of timely access to appropriate medi-
cines has health service and public health ramifications.
For countries with well developed primary care services
such as the UK, the ability of primary care professionals
other than doctors to provide consultations that include
prescribing may improve waiting times to consult and
help manage demand and potential dissatisfaction. The
issue of equitable access to safe and affordable medicine
is critical for lower-income countries where the access
to medicines is compromised by insufficient health facil-
ities and staff, low investment in health and the high
cost of medicines [63]. In these settings if legislative
authority to prescribe is not extended to groups other
than doctors and dentists, using mechanisms such as
patient group directions or standing orders for commu-
nity health workers for a specified essential drug list and
immunisation list may have significant and critical pub-
lic health impact. The contribution of these types of
mechanisms with a broader group of community health
staff is not within the scope of this review but warrants
further investigation.
This review has limitations in that it included only
English language studies and those accessed through
electronic sources and therefore may have excluded evi-
dence from many Scandinavian, African, South East
A s i a na n dS o u t hA m e r i c a nc o u n t r i e s .H o w e v e r ,o u r
review of countries that have legislated for prescribing
authority for professionals other than doctors and den-
tists would suggest that researchers from many of these
countries are likely to publish evidence in English lan-
guage journals, although not necessarily ones that are
indexed through the databases we searched.
Our focus on patient and health service outcomes has
been both a strength and a weakness: while outcomes
are important, the small number of studies finally
included demonstrate how limited the evidence is. We
argue that it is these aspects that most urgently need
investigation. Our focus on solely primary care has also
meant that we have had to exclude some more recent
studies providing evidence from mixed primary and sec-
ondary care settings, aspects such as clinical appropri-
ateness of NMP, e.g. Drennan et al, 2009, Latter et al,
2010, and Bissell et al, 2008 [3,26,35]. In many of these
Bhanbhro et al. BMC Health Services Research 2011, 11:330
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Page 8 of 10studies there were substantial numbers of NMP in pri-
mary care settings. We suggest that secondary data ana-
lysis of some of these studies by health care setting may
be invaluable to providing evidence for service planners,
commissioners and managers.
Conclusions
NMP has been implemented and evolved differently in
different countries. Around twenty countries out of 193
member states of the World Health Organisation
(WHO) provide legal authority to nurses and other pro-
fessionals allied to medicine to prescribe medicines at a
certain level and others are considering introducing leg-
islation. This suggests that internationally twenty first
century policy makers are beginning to look as to how
to move beyond twentieth century established profes-
sional boundaries for the benefit of both public health
and their health care economy. Primary health care is
the setting where timely, and equitable, access to safe
and appropriate medicines is most critical for the well-
being of any population. Our review suggests that there
are substantial gaps in the knowledge base to help evi-
dence based policy making in this arena. We suggest
that this review indicates there is a need for secondary
data analysis of existing studies and commissioning of
new studies that address questions of non-medical pre-
scribing in primary care across a broad range of patient
and health service outcomes, including economic
dimensions.
Additional material
Additional file 1: Non-medical prescribing outcomes based papers
grouped by patient views, professional views and clinical accounts.
Details of the papers included in the review.
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